Skip to main content
Top
Published in: Neurocritical Care 3/2021

01-12-2021 | Guillain-Barré Syndrome | Original work

Predicting Mechanical Ventilation Using the EGRIS in Guillain–Barré Syndrome in a Latin American Country

Authors: Marco Malaga, Aaron Rodriguez-Calienes, Adrian Marquez-Nakamatsu, Katherine Recuay, Luis Merzthal, Diego Bustamante-Paytan, Juan Manuel Sifuentes, Guillermo Castillo-Kohatsu, Carlos Alva-Diaz

Published in: Neurocritical Care | Issue 3/2021

Login to get access

Abstract

Background

Up to one fifth of patients with Guillain–Barré syndrome (GBS) require mechanical ventilation (MV). The Erasmus GBS Respiratory Insufficiency Score (EGRIS) is a clinical predictive model developed in Europe to predict MV requirements among patients with GBS. However, there are significant differences between the Latin American and European population, especially in the distribution of GBS subtypes. Therefore, determining if the EGRIS is able to predict MV in a Latin American population is of clinical significance.

Methods

We retrospectively analyzed clinical and laboratory data of 177 patients with GBS in three Peruvian hospitals. We performed a multivariate logistic regression of the factors making up the EGRIS. Finally, we evaluated the EGRIS discrimination through a receiver operating characteristic curve and determined its calibration through a calibration curve and a Hosmer–Lemeshow test, a test used to determine the goodness of fit.

Results

We found that 14.1% of our patients required MV. One predictive factor of a patient’s need for early MV was the number of days between the onset of motor symptoms and hospitalization. The Medical Research Council sum score did not alter the likelihood of early MV. Bulbar weakness increased the likelihood without showing statistical significance. In contrast, facial weakness was a protective factor of it. The EGRIS was significantly higher in patients who required early MV than in those who did not (P = 0.018). It showed an area under the curve (AUC) of 0.63, with an insignificant Hosmer–Lemeshow test result.

Conclusions

Although the EGRIS was higher in patients who required early MV than in those who did not, it only showed a moderate discrimination capacity (AUC = 0.63). Facial weakness, an item of the EGRIS, was not found to be a predictive factor in our population. We suggest assessing whether these findings are due to subtype predominance and whether a modified version of the EGRIS could improve performance.
Literature
1.
go back to reference Landry O. Note sur la paralysie ascendante aigue. Gaz Hebd Med Paris. 1859;6(472–474):486–8. Landry O. Note sur la paralysie ascendante aigue. Gaz Hebd Med Paris. 1859;6(472–474):486–8.
2.
go back to reference Guillain G, Barré J-A, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose due liquide cephalo-rachidien sans reaction cellulaire. Remarque sur les caracteres clinique et graphiques des reflezes tendinuex. Bull Soc Med Hop Paris. 1916;40:1462–70. Guillain G, Barré J-A, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose due liquide cephalo-rachidien sans reaction cellulaire. Remarque sur les caracteres clinique et graphiques des reflezes tendinuex. Bull Soc Med Hop Paris. 1916;40:1462–70.
3.
go back to reference Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110(2):100–6.CrossRef Bogliun G, Beghi E, Italian GBS Registry Study Group. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110(2):100–6.CrossRef
4.
go back to reference Govoni V, Granieri E. Epidemiology of the Guillain–Barré syndrome. Curr Opin Neurol. 2001;14(5):605–13.CrossRef Govoni V, Granieri E. Epidemiology of the Guillain–Barré syndrome. Curr Opin Neurol. 2001;14(5):605–13.CrossRef
5.
go back to reference Hahn AF. The challenge of respiratory dysfunction in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):871–2.CrossRef Hahn AF. The challenge of respiratory dysfunction in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):871–2.CrossRef
6.
go back to reference Sharshar T, Chevret S, Bourdain F, Raphael J-C. French cooperative group on plasma exchange in Guillain–Barré syndrome. Early predictors of mechanical ventilation in Guillain–Barre syndrome. Crit Care Med. 2003;31(1):278–83.CrossRef Sharshar T, Chevret S, Bourdain F, Raphael J-C. French cooperative group on plasma exchange in Guillain–Barré syndrome. Early predictors of mechanical ventilation in Guillain–Barre syndrome. Crit Care Med. 2003;31(1):278–83.CrossRef
7.
go back to reference Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S. Mortality in mechanically ventilated patients of Guillain Barré syndrome. Ann Indian Acad Neurol. 2011;14(4):262–6.CrossRef Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S. Mortality in mechanically ventilated patients of Guillain Barré syndrome. Ann Indian Acad Neurol. 2011;14(4):262–6.CrossRef
8.
go back to reference Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain–Barré syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64(1):74–7.CrossRef Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain–Barré syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64(1):74–7.CrossRef
9.
go back to reference Wijdicks EFM, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain–Barré syndrome. Arch Neurol. 2003;60(7):947–8.CrossRef Wijdicks EFM, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain–Barré syndrome. Arch Neurol. 2003;60(7):947–8.CrossRef
10.
go back to reference Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael JC, Clair B. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain–Barré syndrome. Intensive Care Med. 2006;32(12):1962–9.CrossRef Orlikowski D, Sharshar T, Porcher R, Annane D, Raphael JC, Clair B. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain–Barré syndrome. Intensive Care Med. 2006;32(12):1962–9.CrossRef
11.
go back to reference Hernández-Torruco J, Canul-Reich J, Frausto-Solís J, Méndex-Castillo JJ. Predictores de falla respiratoria y de la necesidad de ventilación mecánica en el síndrome de Guillain–Barré: una revisión de la literatura. Rev Mex Neurocienc. 2013;14(5):272–80. Hernández-Torruco J, Canul-Reich J, Frausto-Solís J, Méndex-Castillo JJ. Predictores de falla respiratoria y de la necesidad de ventilación mecánica en el síndrome de Guillain–Barré: una revisión de la literatura. Rev Mex Neurocienc. 2013;14(5):272–80.
12.
go back to reference Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):893–8.CrossRef Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain–Barré syndrome. Arch Neurol. 2001;58(6):893–8.CrossRef
13.
go back to reference Toamad U, Kongkamol C, Setthawatcharawanich S, Limapichat K, Phabphal K, Sathirapanya P. Clinical presentations as predictors of prolonged mechanical ventilation in Guillain–Barré syndrome in an institution with limited medical resources. Singapore Med J. 2015;56(10):558–61.CrossRef Toamad U, Kongkamol C, Setthawatcharawanich S, Limapichat K, Phabphal K, Sathirapanya P. Clinical presentations as predictors of prolonged mechanical ventilation in Guillain–Barré syndrome in an institution with limited medical resources. Singapore Med J. 2015;56(10):558–61.CrossRef
14.
go back to reference Wu X, Li C, Zhang B, Shen D, Li T, Liu K, et al. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain–Barré syndrome. Crit Care. 2015;19(1):310.CrossRef Wu X, Li C, Zhang B, Shen D, Li T, Liu K, et al. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain–Barré syndrome. Crit Care. 2015;19(1):310.CrossRef
15.
go back to reference Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsveld R, Garssen MJP, et al. Prediction of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol. 2010;67(6):781–7.PubMed Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsveld R, Garssen MJP, et al. Prediction of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol. 2010;67(6):781–7.PubMed
16.
go back to reference Zúñiga-González EA, Rodríguez-de la Cruz A, Millán-Padilla J. Subtipos electrofisiológicos del síndrome de Guillain–Barré en adultos mexicanos. Rev Med Inst Mex Seguro Soc. 2007;45(5):463–8.PubMed Zúñiga-González EA, Rodríguez-de la Cruz A, Millán-Padilla J. Subtipos electrofisiológicos del síndrome de Guillain–Barré en adultos mexicanos. Rev Med Inst Mex Seguro Soc. 2007;45(5):463–8.PubMed
17.
go back to reference Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013;12(12):1180–8.CrossRef Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013;12(12):1180–8.CrossRef
18.
go back to reference Hughes RAC, Cornblath DR. Guillain–Barré syndrome. Lancet. 2005;366(9497):1653–66.CrossRef Hughes RAC, Cornblath DR. Guillain–Barré syndrome. Lancet. 2005;366(9497):1653–66.CrossRef
19.
go back to reference van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol. 2008;7(10):939–50.CrossRef van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol. 2008;7(10):939–50.CrossRef
20.
go back to reference dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, et al. Zika virus and the Guillain–Barré syndrome—case series from seven countries. N Engl J Med. 2016;375(16):1598–601.CrossRef dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, et al. Zika virus and the Guillain–Barré syndrome—case series from seven countries. N Engl J Med. 2016;375(16):1598–601.CrossRef
21.
go back to reference van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRef van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82.CrossRef
22.
go back to reference Asbury A, Arnason B, Karp H, McFarlin D. Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol. 1978;3(6):565–6.CrossRef Asbury A, Arnason B, Karp H, McFarlin D. Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol. 1978;3(6):565–6.CrossRef
23.
go back to reference Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl 1):S21–4.CrossRef Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl 1):S21–4.CrossRef
24.
go back to reference Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group, et al. Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5):780–8.CrossRef Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group, et al. Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5):780–8.CrossRef
25.
go back to reference Alva-Diaz C, Mori N, Pacheco-Barrios K, Velásquez-Rimachi V, Rivera-Torrejon O, Huerta-Rosario CA, et al. Guía de práctica clínica para el diagnóstico y tratamiento del paciente con síndrome de Guillain-Barré. Neurolgía Argentina. 2020;12(1):36–48.CrossRef Alva-Diaz C, Mori N, Pacheco-Barrios K, Velásquez-Rimachi V, Rivera-Torrejon O, Huerta-Rosario CA, et al. Guía de práctica clínica para el diagnóstico y tratamiento del paciente con síndrome de Guillain-Barré. Neurolgía Argentina. 2020;12(1):36–48.CrossRef
26.
go back to reference Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, IGOS Consortium, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–77.CrossRef Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, IGOS Consortium, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–77.CrossRef
27.
go back to reference Mcgrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain–Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63.CrossRef Mcgrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain–Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–63.CrossRef
28.
go back to reference Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y. Incidence of Guillain–Barré syndrome (GBS) in Latin America and the Caribbean before and during the 2015–2016 Zika virus epidemic: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(8):e0007622.CrossRef Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y. Incidence of Guillain–Barré syndrome (GBS) in Latin America and the Caribbean before and during the 2015–2016 Zika virus epidemic: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(8):e0007622.CrossRef
29.
go back to reference Munayco CV, SotoCabezas MG, Reyes MF, Arica Gutiérrez JA, Napanga SO. [Epidemiology of Guillain–Barré syndrome in Peru]. Rev Peru Med Exp Salud Publica. 2019;36(1):10–6 (Spanish).CrossRef Munayco CV, SotoCabezas MG, Reyes MF, Arica Gutiérrez JA, Napanga SO. [Epidemiology of Guillain–Barré syndrome in Peru]. Rev Peru Med Exp Salud Publica. 2019;36(1):10–6 (Spanish).CrossRef
30.
go back to reference Ballón-Manrique B, Campos-Ramos N. Características clínicas y paraclínicas del síndrome de Guillain–Barré en el Hospital Regional Lambayeque. Rev Neuropsiquiatr. 2017;80(1):22–6.CrossRef Ballón-Manrique B, Campos-Ramos N. Características clínicas y paraclínicas del síndrome de Guillain–Barré en el Hospital Regional Lambayeque. Rev Neuropsiquiatr. 2017;80(1):22–6.CrossRef
31.
go back to reference Castañeda ML, Deza BL. Respuesta clínica al tratamiento con recambio plasmático en pacientes con síndrome de Guillain Barré. Hospital Guillermo Almenara Irigoyen ESSALUD 1995–1998. Rev Neuropsiquiatr. 2000;63(3–4):182–94. Castañeda ML, Deza BL. Respuesta clínica al tratamiento con recambio plasmático en pacientes con síndrome de Guillain Barré. Hospital Guillermo Almenara Irigoyen ESSALUD 1995–1998. Rev Neuropsiquiatr. 2000;63(3–4):182–94.
32.
go back to reference Vásquez C, César J. Costos de tratamiento de pacientes con síndrome Guillain Barré en el servicio de neurología y unidad de cuidados intensivos del Hospital Nacional Edgardo Rebagliati Martins. Trujillo, Peru: Universidad Nacional de Trujillo; 2009. Vásquez C, César J. Costos de tratamiento de pacientes con síndrome Guillain Barré en el servicio de neurología y unidad de cuidados intensivos del Hospital Nacional Edgardo Rebagliati Martins. Trujillo, Peru: Universidad Nacional de Trujillo; 2009.
33.
go back to reference Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain–Barré syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021–8.CrossRef Durand MC, Porcher R, Orlikowski D, Aboab J, Devaux C, Clair B, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain–Barré syndrome: a prospective study. Lancet Neurol. 2006;5(12):1021–8.CrossRef
34.
go back to reference Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, et al. Markers for Guillain–Barré syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst. 2017;22(4):433–9.CrossRef Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, et al. Markers for Guillain–Barré syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst. 2017;22(4):433–9.CrossRef
35.
go back to reference Tan C-Y, Razali SNO, Goh K-J, Shahrizaila N. The utility of Guillain–Barré syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst. 2019;24(2):168–73.CrossRef Tan C-Y, Razali SNO, Goh K-J, Shahrizaila N. The utility of Guillain–Barré syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst. 2019;24(2):168–73.CrossRef
36.
go back to reference Chung HK. Comparison between EGRIS and outcome of Guillain–Barré syndrome: retrospective study in one center [abstract]. Neurology. 2012;78(Suppl 1):P06.144. Chung HK. Comparison between EGRIS and outcome of Guillain–Barré syndrome: retrospective study in one center [abstract]. Neurology. 2012;78(Suppl 1):P06.144.
37.
go back to reference Dourado ME, Félix RH, da Silva WKA, Queiroz JW, Jeronimo SMB. Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand. 2012;125(1):47–53.CrossRef Dourado ME, Félix RH, da Silva WKA, Queiroz JW, Jeronimo SMB. Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand. 2012;125(1):47–53.CrossRef
38.
go back to reference Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, et al. Delayed facial weakness in Guillain–Barré and Miller Fisher syndromes. Muscle Nerve. 2015;51(6):811–4.CrossRef Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, et al. Delayed facial weakness in Guillain–Barré and Miller Fisher syndromes. Muscle Nerve. 2015;51(6):811–4.CrossRef
39.
go back to reference Sekiguchi Y, Misawa S, Suichi T, Amiono H, Shibuya K, Kuwabara S. Facial nerve palsy and disease severity in Guillain–Barre syndrome. J Neurol Sci. 2017;381(Suppl):1073.CrossRef Sekiguchi Y, Misawa S, Suichi T, Amiono H, Shibuya K, Kuwabara S. Facial nerve palsy and disease severity in Guillain–Barre syndrome. J Neurol Sci. 2017;381(Suppl):1073.CrossRef
Metadata
Title
Predicting Mechanical Ventilation Using the EGRIS in Guillain–Barré Syndrome in a Latin American Country
Authors
Marco Malaga
Aaron Rodriguez-Calienes
Adrian Marquez-Nakamatsu
Katherine Recuay
Luis Merzthal
Diego Bustamante-Paytan
Juan Manuel Sifuentes
Guillermo Castillo-Kohatsu
Carlos Alva-Diaz
Publication date
01-12-2021
Publisher
Springer US
Published in
Neurocritical Care / Issue 3/2021
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-021-01218-z

Other articles of this Issue 3/2021

Neurocritical Care 3/2021 Go to the issue